| scholarly article | Q13442814 |
| P50 | author | Rajendra Prasad | Q89926093 |
| P2093 | author name string | Avmeet Kohli | |
| Kasturi Mukhopadhyay | |||
| P2860 | cites work | Biochemical characterization and subcellular localization of the sterol C-24(28) reductase, erg4p, from the yeast saccharomyces cerevisiae. | Q27930059 |
| PDR16 and PDR17, two homologous genes of Saccharomyces cerevisiae, affect lipid biosynthesis and resistance to multiple drugs | Q27930853 | ||
| Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast | Q27932650 | ||
| ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p | Q27936618 | ||
| Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals | Q28293585 | ||
| Role of multidrug resistance P-glycoproteins in cholesterol esterification | Q28301262 | ||
| Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter. | Q32133639 | ||
| Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate | Q33630438 | ||
| Isolation of a putative Candida albicans transcriptional regulator involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation in Saccharomyces cerevisiae | Q33634941 | ||
| Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. | Q33721804 | ||
| Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane | Q33815754 | ||
| Cloning by gene amplification of two loci conferring multiple drug resistance in Saccharomyces | Q33908727 | ||
| Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans | Q33963057 | ||
| Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients | Q33977103 | ||
| Purification, reconstitution, and inhibition of cytochrome P-450 sterol delta22-desaturase from the pathogenic fungus Candida glabrata. | Q33977200 | ||
| Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters | Q33983544 | ||
| Specific chromosome alterations in fluconazole-resistant mutants of Candida albicans | Q33992463 | ||
| Cloning of the late genes in the ergosterol biosynthetic pathway of Saccharomyces cerevisiae--a review | Q34059049 | ||
| Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailin | Q34110565 | ||
| Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences | Q34569070 | ||
| Drug resistance in yeasts--an emerging scenario | Q34695128 | ||
| Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia | Q35131728 | ||
| Molecular biological characterization of an azole-resistant Candida glabrata isolate | Q35138586 | ||
| Plasma membrane translocation of fluorescent-labeled phosphatidylethanolamine is controlled by transcription regulators, PDR1 and PDR3 | Q36268129 | ||
| Sequencing, disruption, and characterization of the Candida albicans sterol methyltransferase (ERG6) gene: drug susceptibility studies in erg6 mutants | Q39558473 | ||
| In vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry | Q39651398 | ||
| Sterols in Candida albicans mutants resistant to polyene or azole antifungals, and of a double mutant C. albicans 6.4. | Q39685100 | ||
| Resistance of Candida albicans to azole antifungal agents | Q40727027 | ||
| Specificity of drug transport mediated by CaMDR1: a major facilitator of Candida albicans | Q40778850 | ||
| The P-glycoprotein multidrug transporter: interactions with membrane lipids, and their modulation of activity | Q41655671 | ||
| Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains | Q42800313 | ||
| Modulation of fluconazole sensitivity by the interaction of mitochondria and erg3p in Saccharomyces cerevisiae | Q43487597 | ||
| CaALK8, an alkane assimilating cytochrome P450, confers multidrug resistance when expressed in a hypersensitive strain of Candida albicans | Q43728432 | ||
| ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators | Q43900293 | ||
| Sterol-dependent regulation of sphingolipid metabolism in Saccharomyces cerevisiae | Q43990141 | ||
| ERG6 and PDR5 regulate small lipophilic drug accumulation in yeast cells via distinct mechanisms | Q44030158 | ||
| Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles | Q44377409 | ||
| Standardization of antifungal susceptibility testing and clinical relevance. | Q45116576 | ||
| Cloning, sequencing, expression and allelic sequence diversity of ERG3 (C-5 sterol desaturase gene) in Candida albicans | Q47940968 | ||
| The yeast multidrug resistance pump, Pdr5p, confers reduced drug resistance in erg mutants of Saccharomyces cerevisiae. | Q52534822 | ||
| Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains. | Q54057901 | ||
| Membrane fluidity affects functions of Cdr1p, a multidrug ABC transporter of Candida albicans. | Q54097600 | ||
| Asymmetric distribution of phosphatidylethanolamine in C. albicans: possible mediation by CDR1, a multidrug transporter belonging to ATP binding cassette (ABC) superfamily. | Q54104444 | ||
| The lipid composition of azole-sensitive and azole-resistant strains of Candida albicans. | Q54423176 | ||
| Coordinate Control of Sphingolipid Biosynthesis and Multidrug Resistance inSaccharomyces cerevisiae | Q57371970 | ||
| Role of multidrug resistance P-glycoproteins in cholesterol biosynthesis | Q70937676 | ||
| Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients | Q71832854 | ||
| Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta5,6-desaturation | Q72989562 | ||
| Efflux-mediated resistance to fluconazole could be modulated by sterol homeostasis in Saccharomyces cerevisiae | Q74138000 | ||
| Identification of polymorphic mutant alleles of CaMDR1, a major facilitator of Candida albicans which confers multidrug resistance, and its in vitro transcriptional activation | Q77323771 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3695-3705 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Drug susceptibilities of yeast cells are affected by membrane lipid composition | |
| P478 | volume | 46 |
| Q47609964 | ABC transporters coupled with the elevated ergosterol contents contribute to the azole resistance and amphotericin B susceptibility |
| Q46529075 | Alanine scanning of transmembrane helix 11 of Cdr1p ABC antifungal efflux pump of Candida albicans: identification of amino acid residues critical for drug efflux. |
| Q36235037 | An update on antifungal targets and mechanisms of resistance in Candida albicans |
| Q46500458 | Anti-biofilm mechanisms of 3,5-di-tert-butylphenol against clinically relevant fungal pathogens |
| Q36658607 | Antifungal Action of Methylene Blue Involves Mitochondrial Dysfunction and Disruption of Redox and Membrane Homeostasis in C. albicans. |
| Q34088663 | Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicans |
| Q28475655 | Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi |
| Q47329636 | Azole resistance in a Candida albicans mutant lacking the ABC transporter CDR6/ROA1 depends on TOR signaling. |
| Q50035488 | Brr6 and Brl1 locate to nuclear pore complex assembly sites to promote their biogenesis. |
| Q36413446 | CD44 promotes multi-drug resistance by protecting P-glycoprotein from FBXO21-mediated ubiquitination |
| Q28477740 | Calcineurin signaling and membrane lipid homeostasis regulates iron mediated multidrug resistance mechanisms in Candida albicans |
| Q58490177 | Cdr2p contributes to fluconazole resistance in Candida dubliniensis clinical isolates |
| Q28480747 | Comparative lipidomics in clinical isolates of Candida albicans reveal crosstalk between mitochondria, cell wall integrity and azole resistance |
| Q33894971 | Comparative lipidomics of azole sensitive and resistant clinical isolates of Candida albicans reveals unexpected diversity in molecular lipid imprints |
| Q37544574 | Curcumin targets cell wall integrity via calcineurin-mediated signaling in Candida albicans |
| Q44674010 | Decrease of H2O2 plasma membrane permeability during adaptation to H2O2 in Saccharomyces cerevisiae. |
| Q92239128 | Decreasing Cell Population of Individual Candida Species Does Not Impair the Virulence of Candida albicans and Candida glabrata Mixed Biofilms |
| Q34049370 | Divergent signature motifs of nucleotide binding domains of ABC multidrug transporter, CaCdr1p of pathogenic Candida albicans, are functionally asymmetric and noninterchangeable |
| Q43016322 | Drug resistance is affected by colocalization of P-glycoproteins in raft-like structures unexpected in eggshells of the nematode Haemonchus contortus |
| Q38708362 | Drug resistance mechanisms and their regulation in non-albicans Candida species |
| Q40565750 | ERG6 gene deletion modifies Kluyveromyces lactis susceptibility to various growth inhibitors. |
| Q92623988 | Effects of cholesterol content on activity of P-glycoproteins and membrane physical state, and consequences for anthelmintic resistance in the nematode Haemonchus contortus |
| Q47675174 | Elimination of the last reactions in ergosterol biosynthesis alters the resistance of Saccharomyces cerevisiae to multiple stresses |
| Q33937992 | Functional analysis of CaIPT1, a sphingolipid biosynthetic gene involved in multidrug resistance and morphogenesis of Candida albicans. |
| Q33585962 | Functional characterization and localization of Pneumocystis carinii lanosterol synthase |
| Q35697281 | Functional characterization of Candida albicans ABC transporter Cdr1p. |
| Q46699248 | Functional characterization of the CgPGS1 gene reveals a link between mitochondrial phospholipid homeostasis and drug resistance in Candida glabrata |
| Q28469241 | Genome-wide fitness test and mechanism-of-action studies of inhibitory compounds in Candida albicans |
| Q43263499 | Genome-wide transcriptional analysis of Saccharomyces cerevisiae during industrial bioethanol fermentation |
| Q35666568 | In vitro effect of malachite green on Candida albicans involves multiple pathways and transcriptional regulators UPC2 and STP2. |
| Q38448000 | Increased resistance to anthelmintics of Haemonchus contortus eggs associated with changes in membrane fluidity of eggshells during embryonation |
| Q42563449 | Insight into pleiotropic drug resistance ATP-binding cassette pump drug transport through mutagenesis of Cdr1p transmembrane domains. |
| Q40523140 | Insight into the Kluyveromyces lactis Pdr1p regulon |
| Q40770175 | Insights into the mode of action of anticandidal herbal monoterpenoid geraniol reveal disruption of multiple MDR mechanisms and virulence attributes in Candida albicans |
| Q30885679 | Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways |
| Q35854764 | Involvement of PDK1, PKC and TOR signalling pathways in basal fluconazole tolerance in Cryptococcus neoformans |
| Q46850609 | Lipid engineering reveals regulatory roles for membrane fluidity in yeast flocculation and oxygen-limited growth |
| Q36596097 | Lipidomics and in vitro azole resistance in Candida albicans |
| Q93116354 | MFS transporter from Botrytis cinerea provides tolerance to glucosinolate-breakdown products and is required for pathogenicity |
| Q35164903 | Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols |
| Q41943919 | Membrane fluidity and lipid composition of fluconazole resistant and susceptible strains of Candida albicans isolated from diabetic patients |
| Q37734737 | Membrane sphingolipid-ergosterol interactions are important determinants of multidrug resistance in Candida albicans |
| Q43876978 | Molecular characterization of mercury resistant bacteria inhabiting polluted water bodies of different geographical locations in India. |
| Q35221728 | Molecular mechanisms of action of herbal antifungal alkaloid berberine, in Candida albicans |
| Q35165969 | Molecular mechanisms of itraconazole resistance in Candida dubliniensis |
| Q92666321 | Multi-omics Signature of Candida auris, an Emerging and Multidrug-Resistant Pathogen |
| Q35983675 | Multidrug resistance in yeast Candida |
| Q42277119 | Mutation of the CgPDR16 gene attenuates azole tolerance and biofilm production in pathogenic Candida glabrata |
| Q35656711 | Mutational Analysis of Intracellular Loops Identify Cross Talk with Nucleotide Binding Domains of Yeast ABC Transporter Cdr1p. |
| Q54320722 | Mutual co-regulation between GPI-N-acetylglucosaminyltransferase and ergosterol biosynthesis in Candida albicans. |
| Q38155848 | Novel Regulatory Mechanisms of Pathogenicity and Virulence to Combat MDR in Candida albicans |
| Q36832670 | Novel yeast-based strategy unveils antagonist binding regions on the nuclear xenobiotic receptor PXR |
| Q57174950 | Overexpression or Deletion of Ergosterol Biosynthesis Genes Alters Doubling Time, Response to Stress Agents, and Drug Susceptibility in |
| Q36198245 | Parallel genetic changes and nonparallel gene-environment interactions characterize the evolution of drug resistance in yeast |
| Q36955059 | Pleiotropic effects of the vacuolar ABC transporter MLT1 of Candida albicans on cell function and virulence. |
| Q33315163 | Propofol lipidic infusion promotes resistance to antifungals by reducing drug input into the fungal cell |
| Q54545287 | Proton pumping ATPase mediated fungicidal activity of two essential oil components. |
| Q27935075 | Repression of ergosterol biosynthesis is essential for stress resistance and is mediated by the Hog1 MAP kinase and the Mot3 and Rox1 transcription factors. |
| Q35878982 | Role for cell density in antifungal drug resistance in Candida albicans biofilms |
| Q41553491 | Sesamol: a natural phenolic compound with promising anticandidal potential |
| Q60047553 | Strong Synergism of Palmatine and Fluconazole/Itraconazole Against Planktonic and Biofilm Cells of Species and Efflux-Associated Antifungal Mechanism |
| Q33779587 | Synthetic cytotoxicity: digenic interactions with TEL1/ATM mutations reveal sensitivity to low doses of camptothecin |
| Q37548771 | Synthetic multivalent antifungal peptides effective against fungi |
| Q35548864 | Tampering with cell division by using small-molecule inhibitors of CDK-CKS protein interactions |
| Q38837326 | Targeting the fungal calcium-calcineurin signaling network in overcoming drug resistance |
| Q33560121 | The amino acid residues of transmembrane helix 5 of multidrug resistance protein CaCdr1p of Candida albicans are involved in substrate specificity and drug transport |
| Q39077878 | Unexpected link between iron and drug resistance of Candida spp.: iron depletion enhances membrane fluidity and drug diffusion, leading to drug-susceptible cells |
| Q34594448 | Use of nonionic surfactants for improvement of terpene production in Saccharomyces cerevisiae. |
| Q28818537 | Widespread Genetic Incompatibilities between First-Step Mutations during Parallel Adaptation of Saccharomyces cerevisiae to a Common Environment |
Search more.